Increased specificity of diagnostic tests with recombinant major bee venom allergen phospholipase A2

Clinical and Experimental Allergy

Volumn 27, Issue 8, 1997, Pages 915-920

  Muller U ^a,c   Fricker, M ^a   Wymann, D ^b   Blaser, K ^b   Crameri, R ^b  

^a Spital Netz Bern   (Switzerland)

^b SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^c Medical Division   (Switzerland)

Author keywords

Bee venom allergy; Phospholipase A2; Recombinant allergens; Skin tests; Specific IgE

Indexed keywords

PHOSPHOLIPASE A2;

ALLERGY; ARTICLE; BEE; BEE STING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN TEST;

ALLERGENS; ANTIBODY SPECIFICITY; BEE VENOMS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN E; INJECTIONS, SUBCUTANEOUS; INTRADERMAL TESTS; PHOSPHOLIPASES A; REAGENT KITS, DIAGNOSTIC; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SKIN TESTS;

EID: 0030832508     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb01233.x     Document Type: Article

References (23)

1. Müller U. Epidemiology of insect sting allergy. In: Burr ML, ed. Epidemiology of clinical allergy. Monogr Allergy 1993; 31:131-46.
2. Sobotka AK, Franklin RM, Adkinson NF, Valentine MD, Baer H, Lichtenstein LM. Allergy to insect stings II. Phospholipase A2: The major allergen in honey bee venom. J Allergy Clin Immunol 1976; 57:29-40.
3. Müller U, Dudler T, Schneider T, Crameri R, Fischer H, Skrbic D, Maibach R, Blaser K, Suter M. Type I skin reactivity to native and recombinant phospholipase A2 from honey bee venom is similar. J Allergy Clin Immunol 1995; 96:395-402.
4. Kuchler K, Gmachl M, Sippl MJ, Kreil G. Analysis of the cDNA for phospholipase A2 from honey bee venom glands. Eur J Biochem 1989; 184:249-54.
5. Dudler T, Chen WQ, Wang S, Schneider T, Annand RR, Dempcy RO, Crameri R, Suter M. High level expression in Escherischia coli and rapid purification of enzymatically active honey bee venom phospholipase A2. Biochim Biophys Acta 1992; 1165:201-10.
6. Schneider T, Lang AB, Carballido JM, Santamaria Babi LF, Dudler T, Kägi M, Blaser K, Suter M. Human monoclonal or polyclonal antibodies recognize predominantly discontinuous epitopes on bee venom phospholipase A2. J Allergy Clin Immunol 1994; 94:61-70.
7. Dudler T, Schneider T, Annand RR, Gelb M, Suter M. Antigenic surface of the bee venom allergen phospholipase A2. J Immunol 1994; 152:5514-22.
8. Förster E, Dudler T, Gmachl M, Aberer W, Urbanek R, Suter M. Natural and recombinant enzymatically active or inactive bee venom phospholipase A2 has the same potency to release histamine from basophils in patients with hymenoptera allergy. J Allergy Clin Immunol 1995; 95:1229-35.
9. Scheiner O, Kraft D. Basic and practical aspects of recombinant allergens. Allergy 1995; 50:384-91.
10. Müller U, Reisman R, Wypych J, Elliott W, Steger R, Walsh S, Arbesman C. Comparison of vespid venoms collected by electrostimulation and by venom sac extraction. J Allergy Clin Immunol 1981; 68:254-61.
11. Müller U. Insect sting allergy: Clinical picture, diagnosis and treatment. Stuttgart, New York: Gustav Fischer Verlag, 1990.
12. Müller U, Mosbech H. Position paper: Immunotherapy with hymenoptera venoms. EAACI Subcommittee on insect venom allergy. Allergy 1993; 48 Suppl 14:36-46.
13. Müller U. Diagnosis and management of hymenoptera venom allergy. In: Bousquet J, Michel FB, eds Advances in Allergology and Clinical Immunology. Paris 1992: The Parthenon Publishing Group: 611-22.
14. Blaauw P, Smithuis L. The evaluatiuon of the common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of an in hospital insect sting. J Allergy Clin Immunol 1985; 75:556-62.
15. van der Linden PWG, Hack C, Struyvenberg A, van der Zwan JK. Insect sting challenge in 324 subjects with a previous anaphylactic reaction: Current criteria for insect venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis. J Allergy Clin Immunol 1994; 94:151-9.
16. Hoffman D, Jacobson R. Allergens of Hymenoptera venom XII: How much venom is in a sting? Ann Allergy 1984; 52:276-8.
17. Müller U, Helbling A, Berchtold E. Immunotherapy with honey bee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol 1992; 89:529-35.
18. Aukrust L, Einarsson R, Oehman S, Johansson SGO. Crossed radioimmunoelectrophoretic studies of bee venom allergens. Allergy 1982; 37:265-71.
19. Einarsson R. Monitoring of antibodies in patients on immunotherapy with insect venoms by immunoblotting. Int Archs Allergy appl Immunol 1987; 83:217-9.
20. Skrbic D, Fischer H, Weber M, Müller U. Comparison of RAST, Magic Lite and CAP for the diagnosis of hymenoptera venom allergy. Allergy and Clin Immunol News 1994; Suppl 2: 498.
21. Kemeny DM, Banks B, Lawrence A, Pearce F. The purification of hyaluronidase from the venom of the honey bee (Apis mellifera). Biochem Int 1981; 2:145-51.
22. Weber A, Schröder H, Thalberg K, März L. Specific interaction of IgE antibodies with a carbohydrate epitope of honey bee venom phospholipase A2. Allergy 1987; 42:464-70.
23. Tretter V, Altmann F, Kubelka V, März L, Becker WM. Fucose α 1,3-linked to the core region of N-glycans creates an important epitope for IgE from honey bee venom allergic individuals. Int Arch Allergy Immunol 1993; 102:259-66.